EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species
EnhancerAtlas 2.0
TagContent
EnhancerAtlas ID
HS155-14720 
Organism
Homo sapiens 
Tissue/cell
Ovary 
Coordinate
chrX:40034200-40036260 
TF binding sites/motifs
Number: 7             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
ArntlMA0603.1chrX:40036088-40036098GCACGTGACC-6.02
RREB1MA0073.1chrX:40034411-40034431GGGGGTGGGGTGGGGCGGGG-6.18
RREB1MA0073.1chrX:40036206-40036226CCCCACCCCACCCCCTACCT+7.21
RREB1MA0073.1chrX:40036201-40036221CCCCACCCCACCCCACCCCC+7.67
RREB1MA0073.1chrX:40034406-40034426GGGCTGGGGGTGGGGTGGGG-7.6
ZfxMA0146.2chrX:40034513-40034527CAGGCCCCGGCTGG-6.11
ZfxMA0146.2chrX:40035598-40035612CCGGCCTCGGCCTC+6.28
Number of super-enhancer constituents: 28             
IDCoordinateTissue/cell
SE_01309chrX:40032735-40036795Adrenal_Gland
SE_10489chrX:40028005-40037299CD19_Primary
SE_12441chrX:40028224-40037012CD3
SE_13187chrX:40029966-40036585CD34_Primary_RO01480
SE_13805chrX:40028268-40037234CD34_Primary_RO01536
SE_14344chrX:40029761-40037049CD34_Primary_RO01549
SE_15054chrX:40026645-40037112CD4_Memory_Primary_7pool
SE_26729chrX:40030073-40036950Esophagus
SE_31755chrX:40030098-40036960Gastric
SE_32909chrX:40033848-40036162H1
SE_34319chrX:40025113-40037081HCT-116
SE_39958chrX:40029745-40037040K562
SE_41477chrX:40032964-40037003Left_Ventricle
SE_42747chrX:40030207-40037520Lung
SE_49191chrX:40030107-40036942Right_Atrium
SE_52969chrX:40029971-40037549Small_Intestine
SE_54123chrX:40032886-40037231Spleen
SE_55438chrX:40032592-40037070Thymus
SE_56999chrX:40033538-40036784VACO_400
SE_57737chrX:40034438-40036171VACO_503
SE_59437chrX:40011613-40049393Ly3
SE_60054chrX:40006843-40037107Ly4
SE_61279chrX:40005072-40049257HBL1
SE_61737chrX:40005446-40039231Toledo
SE_62904chrX:40005186-40037678Tonsil
SE_65537chrX:40032894-40036865Pancreatic_islets
SE_66639chrX:40032989-40035974Jurkat
SE_68820chrX:40032750-40036863H9
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 2             
ChromosomeStartEnd
chrX4003437740034649
chrX4003469440035505
Enhancer Sequence
GCTATCTGAC CACATTTGTC TGGTCCCTCT GAGAATCCAC GTTTTCTAGC CCGAGAAGGG 60
GCAGGCGGCC CTCATGGCGC CTCCTTCGGC GGTTTCCTGG CGAAGCGCCC ATCCTCCCCA 120
AGCACCAGGA ACGGAGGCCG TCCATATTAA TACTCGCGGG CAGCCTGTTC TGACCTATAC 180
TGTCATTTTT TCCATCGGTC GGGATCGGGC TGGGGGTGGG GTGGGGCGGG GGCTCTCCTC 240
CGAGGGGCTC AGCACGGATC GTTGGGTTTT CCCCGGCGAA CTTAACACGG AGGCAAAAGG 300
GGCAGATGGA AACCAGGCCC CGGCTGGCCC CGCGCGCGTA AGCGCGGCAC TCAGCAGCTC 360
GACGCAAAGC CAGGGCTGGA TTTTCGCGGC CCGGGCCCGG CGGCCGCCCA GCGCCCGCGC 420
GATCCTCTCT CCTTCGGGTT GAGCAAACGT GGTCGCCTAA TTCCGCCCGG GAGACAGCAG 480
CTGTGCGGCG AGAGGGGGAG AAAAAATATC GCAACTTTTC CAACAGAAAG TGTGTGCGCA 540
CACGAGAGGT GAAGGCCCAC CCCGATTCTG TGCACGTATC GACACAGCAT CTAATCAGTG 600
TCACTGCCAG GAATACGCTT CCGCGGCGGG CGACACCGCC GCCCTCGCCA ACCTGCAGGA 660
GGGAGGGGGG ATGCAAATGG CGTCTCGCGT CGTCCTAGAC TCCGCGCAGC ACCCGCTACC 720
GCGACTCCAA GCAGACGTTG CAGCAAACTG GGGTGCAGCG TCTGGGGACG CGAACGCGCA 780
GGCGGCCCGA GCGGTCGCAG GGAAGAGGAA CTAGCACCAC TCCCCGCTAC GAGACCGTTC 840
CCCGCCCCCA CCTCCGGAAG AGCCGCCCTT ACTCGACTGG GGTGAGGGGC GGGAAACTTT 900
GCAAGAAGAC TGTTCCGCGC CTTCCCCGCG TGGCACCTCA GAAGAACGTG GGTGGGTTTC 960
CCGTCCGAGG CCAGACCACG CTACCCTACT TTTCCAGGTT TCGGACCTGA ACCTCGTGGA 1020
CTACGGGAGG GAGAGTACAT TTCGGGCCAC TGCGGGGGGC GGAGGGACAC CAAAGACAGG 1080
CGTCTTCAAG GGTTCTGGCA GATGGCCAAG TTTGTGTCCT TTCCCTCCCA CGCTAGAGTA 1140
GCGCACGCCA CTTTGGGGAA GCGTGAGACC GTTCACCACC GGCCACGAGG CCACCAATGT 1200
CTTCCAGGTG GGGCCGATGG TTTGTCTGCA GCACTCCCTT CCGCCTTGCG GTCCTCGCCT 1260
GGCTCCCACA GTCCTGGGGA GCCCCCAGAG CTAGCCCGCG TCTTCCCTCG CCCGCTCTTC 1320
CGGGGGAAAG GGAGGCTGTT TGTGTGGTGT GTAGCCCCGC TCCGGCTTGC ACCCCCGCGA 1380
GCCACCTCGC AGCCCTCCCC GGCCTCGGCC TCACGGATCC CCTCCCGGAG TAGCCCCGCG 1440
GGCCCCCCCG CCATGCGTAA TGGGGCGCCC CTGGGACGCA GGCGGGGATG GCGGTTCCGG 1500
TCGTTCCGGG ATTTGCGTGC AAGAAGAAAA CAAGGCCGGC GACTACAAGA GCGGCGACTC 1560
CATTCTTGGG GTTCAGACGC CCTCGCAGCC TCCGCGTCGG TTCCGCTCTC GCCCCGGGAG 1620
CCCGCTTCCG TGTCCCTGCC CCCGCCCCCC AACGATTCCT CGTCCGGCCC GTGCCGCACC 1680
ACGCGGAGCT CCGCGCGCCC TGGCTCCCAC ACCGGTCCCT CCATAACTCG CGCTCCTCCC 1740
TCGCTCCGGG CTCGGGGAGC CGCTCGCTCC CAGCGCCCAG AGTCAGCCGG TTCCACCTTC 1800
GGCTGCGAGA GCCGCCGCCC CGCGCCACCC CCGCCCGGCC CGGCCCTTGT CCCAGCCCGG 1860
CTCCCCCGCC AGCTGCGCCG CCACCGCCGC ACGTGACCCG CCCCCGTCGC GGCTTCCGCT 1920
GAGCTGCCTG TTCCGGGGCA CAAACAATTT TTGCTCTGAC GCGGGGTCTC TCGGGGGCCC 1980
TGGCGTCCTC TACTCCCTGC TCCCCACCCC ACCCCACCCC CTACCTTCCG GGTAGGAGAA 2040
CTCAAAACAA CTCGCTGACC 2060